TREATMENT OUTCOME OF CHEMOTHERAPY AND ANTIRETROVIRAL THERAPY AND COTRIMOXAZOLE PREVENTIVE THERAPY IN TUBERCULOSIS PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS COINFECTION

Abstract

Objective: In developing countries like India, the fatality rate of tuberculosis (TB) coinfected with human immunodeficiency virus (HIV) is still at high rate and imposes significant challenge among the physicians. The present study was conducted to evaluate management outcomes of combined antiretroviral therapy (ART) and chemotherapy or cotrimoxazole preventive therapy (CPT) in TB/HIV co-infected patients. Methods: The study was conducted on 3512 confirmed TB patients who were treated with ART and CPT therapy. Out of these, HIV positive was 58 cases and HIV negative was 3414 cases. HIV cases the algorithm KHB- Statpak- Unigold were used. Patient started CPT. Results: Percentage of TB and HIV coinfection was 58 and the coinfection was greater in 20–40-year age groups and 2 times higher in PTB sputum-positive cases. Among the extrapulmonary TB cases, 76% took CPT + ART. The treatment success was 86%. Conclusion: Thus, CPT therapy must be established in all centers and compulsory HIV screening must be implicated throughout the country.